Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Industry
Pharmaceutical Preparations
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Iterum Therapeutics Ltd (to 5/1/2018)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 111 % -75.9%
Debt-to-equity -317 % -215%
Return On Equity 349 %
Return On Assets -161 % -179%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.5M shares +111%
Entity Public Float 13.7M USD -62.7%
Common Stock, Value, Issued 227K USD +74.6%
Weighted Average Number of Shares Outstanding, Basic 20M shares +53.7%
Weighted Average Number of Shares Outstanding, Diluted 20M shares +53.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 18.9M USD -47.6%
General and Administrative Expense 7.55M USD -4.08%
Operating Income (Loss) -26.5M USD +39.8%
Nonoperating Income (Expense) -3.74M USD -128%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30.2M USD +1.08%
Income Tax Expense (Benefit) 357K USD -37.6%
Net Income (Loss) Attributable to Parent -30.6M USD +1.75%
Earnings Per Share, Basic -1.99 USD/shares +18.4%
Earnings Per Share, Diluted -1.99 USD/shares +18.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.4M USD +178%
Inventory, Net 0 USD
Assets, Current 15.9M USD -58.9%
Property, Plant and Equipment, Net 30K USD -49.2%
Operating Lease, Right-of-Use Asset 264K USD -58.1%
Intangible Assets, Net (Excluding Goodwill) 432K USD -79.9%
Other Assets, Noncurrent 407K USD -83.1%
Assets 15.9M USD -59.9%
Accounts Payable, Current 835K USD -84.9%
Employee-related Liabilities, Current 1.77M USD -16.2%
Accrued Liabilities, Current 3.49M USD -61.4%
Liabilities, Current 18.7M USD +14.1%
Operating Lease, Liability, Noncurrent 16K USD -98.6%
Other Liabilities, Noncurrent 16K USD -98.6%
Liabilities 27.4M USD -24.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2K USD -33.3%
Retained Earnings (Accumulated Deficit) -479M USD -6.81%
Stockholders' Equity Attributable to Parent -11.5M USD -435%
Liabilities and Equity 15.9M USD -59.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -36.4%
Net Cash Provided by (Used in) Financing Activities 7.22M USD +2971%
Net Cash Provided by (Used in) Investing Activities 7.21M USD +41.2%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 22.7M shares +74.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.32M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 22K USD -85.5%
Deferred Tax Assets, Valuation Allowance 41.7M USD +14.2%
Operating Lease, Liability 268K USD -56.8%
Depreciation 7K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.6M USD +1.74%
Lessee, Operating Lease, Liability, to be Paid 279K USD -59.3%
Property, Plant and Equipment, Gross 363K USD -0.82%
Operating Lease, Liability, Current 268K USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 279K USD -29.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -83.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 300K USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 41.5M USD +15.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 2.02M USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 300K USD +4.17%
Operating Lease, Payments 399K USD +11.8%
Amortization of Intangible Assets 429K USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%